EPTIS
BAM Logo

ESEAP: Greek EQA Scheme. Part 12 - Viral Markers Screening (In collaboration with EUROREFLAB - Belgium, The Netherlands, Denmark, Finland, Greece and Cyprus)

EPTIS factsheet 275868 | Last revision 2016-11-10 | URL: https://www.eptis.bam.de/pts275868 https://www.eptis.bam.de/pts275868

PT provider
PT provider ESEAP ESEAP
Based in Greece
Language(s) Greek-English
Remarks
Keywords
Product groups Human test material
Testing fields Medical analysis
Technical details
Test item Tested property Testing method
Human sera, lyophilized HBsAg -
Anti HBc -
Anti HBs -
HCV antibody -
HIV 1/2 -
Anti treponemic antibodies -
HTLV antibody -
Aims of the PT scheme
Target group of participants Clinical Laboratories
Linked to specific legislation / standards
Additional, subsidiary aims validation of testing methods
Number of participants
Accredited or otherwise reviewed by a 3rd party

Recognised by TÜV Hellas on the basis of ISO 9001

Operation is commissioned / requested by
Fees and frequency
Participation fee 95 Euro + VAT per analyte per distribution
Regularly operated Yes (trimonthly)
Year of first operation 2017
Contact details of the PT provider
Provider Contact person
ESEAP
47, Alopekis str.
10676 Athens
Greece

Phone: +30 2107292403
Fax: +30 2103645392
Web: http://www.eseap.gr http://www.eseap.gr
Dr. Otto Panagiotakis
Phone: +30 6978904022
Fax: +30 2103645392
Email: info@eseap.gr info@eseap.gr
If you find any mistakes please contact the responsible EPTIS coordinator in Greece, Ms Vicky Nikou. Ms Vicky Nikou.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.21